| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,484 |
22,883 |
$5.28M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,804 |
20,296 |
$5.23M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,319 |
9,369 |
$3.47M |
| G0378 |
Hospital observation service, per hour |
7,958 |
6,679 |
$3.43M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,518 |
10,835 |
$1.38M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
33,075 |
7,150 |
$749K |
| OP250 |
|
45,493 |
32,033 |
$691K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
18,568 |
4,628 |
$461K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,936 |
2,807 |
$349K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,967 |
7,976 |
$317K |
| OP710 |
|
3,234 |
2,984 |
$309K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,624 |
4,968 |
$281K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,071 |
9,015 |
$260K |
| 93975 |
|
2,245 |
2,153 |
$255K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,334 |
14,656 |
$250K |
| 95811 |
|
115 |
115 |
$231K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,982 |
3,717 |
$228K |
| OP270 |
|
3,635 |
2,923 |
$201K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
755 |
711 |
$198K |
| OP379 |
|
2,249 |
2,112 |
$192K |
| 80053 |
Comprehensive metabolic panel |
27,865 |
24,368 |
$190K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,970 |
10,960 |
$189K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,983 |
25,536 |
$177K |
| 71045 |
Radiologic examination, chest; single view |
12,225 |
11,256 |
$176K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,995 |
1,914 |
$175K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,518 |
1,461 |
$152K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,366 |
3,186 |
$138K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,857 |
2,669 |
$131K |
| OP370 |
|
1,194 |
1,061 |
$115K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
745 |
706 |
$115K |
| OP272 |
|
3,608 |
3,095 |
$102K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
459 |
440 |
$91K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,517 |
6,678 |
$91K |
| 93017 |
|
713 |
672 |
$90K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
3,759 |
858 |
$89K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,804 |
2,930 |
$86K |
| 36415 |
Collection of venous blood by venipuncture |
28,611 |
24,220 |
$86K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,921 |
2,755 |
$85K |
| 97010 |
|
10,744 |
2,443 |
$84K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,944 |
1,052 |
$84K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
384 |
373 |
$80K |
| 71046 |
Radiologic examination, chest; 2 views |
3,540 |
3,444 |
$76K |
| OP258 |
|
18,922 |
14,788 |
$75K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,661 |
1,544 |
$74K |
| 95816 |
|
301 |
298 |
$70K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,048 |
1,022 |
$63K |
| 97162 |
|
1,744 |
1,649 |
$61K |
| 76830 |
Ultrasound, transvaginal |
1,109 |
1,085 |
$59K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,205 |
500 |
$57K |
| 84484 |
|
9,254 |
7,866 |
$55K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
658 |
602 |
$52K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,699 |
1,519 |
$51K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,117 |
1,099 |
$50K |
| 83735 |
|
13,435 |
11,718 |
$45K |
| 97164 |
|
1,312 |
1,257 |
$44K |
| OP279 |
|
7,612 |
5,605 |
$42K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
712 |
689 |
$40K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,645 |
3,388 |
$39K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,306 |
2,127 |
$36K |
| 85610 |
|
10,233 |
9,372 |
$36K |
| 73630 |
|
1,767 |
1,679 |
$35K |
| 85730 |
|
9,199 |
8,572 |
$34K |
| 82962 |
|
6,067 |
4,468 |
$30K |
| 83880 |
|
2,459 |
2,221 |
$29K |
| 88312 |
|
678 |
647 |
$29K |
| 73130 |
|
1,241 |
1,150 |
$28K |
| 83690 |
|
9,778 |
8,997 |
$28K |
| 73610 |
|
1,429 |
1,362 |
$27K |
| 93971 |
|
391 |
363 |
$25K |
| 88313 |
|
703 |
667 |
$25K |
| 82150 |
|
5,803 |
5,450 |
$23K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
413 |
385 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,876 |
3,648 |
$21K |
| 86803 |
|
3,764 |
3,510 |
$21K |
| 80061 |
Lipid panel |
2,172 |
2,038 |
$21K |
| 73562 |
|
959 |
877 |
$21K |
| 84702 |
|
3,685 |
3,481 |
$21K |
| 73030 |
|
933 |
857 |
$20K |
| 97113 |
|
340 |
121 |
$19K |
| 0240U |
|
579 |
548 |
$19K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
150 |
133 |
$19K |
| 81001 |
|
6,743 |
6,314 |
$18K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
708 |
627 |
$18K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
573 |
557 |
$16K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
417 |
385 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,924 |
2,583 |
$16K |
| 97161 |
|
397 |
392 |
$16K |
| 84100 |
|
3,398 |
2,929 |
$15K |
| 86901 |
|
2,058 |
1,849 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
978 |
899 |
$14K |
| 81025 |
|
5,806 |
5,299 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
335 |
321 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,552 |
1,268 |
$13K |
| 82550 |
|
3,294 |
3,076 |
$13K |
| 86900 |
|
2,058 |
1,851 |
$13K |
| 87040 |
|
1,418 |
1,249 |
$12K |
| 86850 |
|
1,942 |
1,808 |
$12K |
| 96376 |
|
1,094 |
800 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,881 |
1,755 |
$11K |
| 81003 |
|
7,117 |
6,749 |
$11K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
496 |
449 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
756 |
723 |
$10K |
| S9480 |
Intensive outpatient psychiatric services, per diem |
14 |
12 |
$10K |
| 97014 |
|
1,407 |
349 |
$10K |
| 73110 |
|
475 |
430 |
$9K |
| 90715 |
|
1,116 |
1,054 |
$9K |
| 83605 |
|
1,373 |
1,245 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
562 |
541 |
$9K |
| 97116 |
|
562 |
246 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
380 |
367 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
756 |
723 |
$8K |
| 87186 |
|
1,416 |
1,328 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,336 |
1,195 |
$7K |
| 12001 |
|
116 |
114 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
747 |
483 |
$7K |
| 87070 |
|
1,207 |
1,131 |
$7K |
| A0425 |
Ground mileage, per statute mile |
409 |
398 |
$7K |
| 96367 |
|
372 |
369 |
$6K |
| 97163 |
|
159 |
159 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,352 |
1,277 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
192 |
156 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
24 |
24 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,430 |
4,730 |
$5K |
| 93970 |
|
55 |
51 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
131 |
127 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
230 |
61 |
$4K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
19 |
17 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
1,862 |
1,667 |
$4K |
| 73564 |
|
260 |
243 |
$4K |
| 82607 |
|
327 |
310 |
$4K |
| 87340 |
|
1,056 |
986 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,273 |
7,288 |
$4K |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
164 |
160 |
$4K |
| 10060 |
|
66 |
64 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
14 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
539 |
495 |
$3K |
| 84439 |
|
655 |
609 |
$3K |
| 0002A |
|
82 |
82 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
55 |
49 |
$3K |
| A9270 |
Non-covered item or service |
4,950 |
2,790 |
$3K |
| 84436 |
|
725 |
705 |
$3K |
| 0001A |
|
76 |
76 |
$3K |
| 72110 |
|
50 |
49 |
$2K |
| 85027 |
|
1,147 |
1,000 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,409 |
1,263 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
74 |
65 |
$2K |
| 73502 |
|
85 |
81 |
$2K |
| 88304 |
|
119 |
116 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,109 |
1,917 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
684 |
598 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
985 |
859 |
$2K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
176 |
154 |
$2K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
168 |
149 |
$2K |
| 85378 |
|
422 |
405 |
$1K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
13 |
$1K |
| J1756 |
Injection, iron sucrose, 1 mg |
46 |
16 |
$1K |
| 80305 |
|
444 |
401 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,864 |
1,720 |
$1K |
| 71101 |
|
57 |
50 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
51 |
51 |
$1K |
| 85379 |
|
500 |
450 |
$1K |
| 12011 |
|
44 |
39 |
$1K |
| 73140 |
|
28 |
28 |
$1K |
| 85007 |
|
911 |
792 |
$945.94 |
| 45384 |
|
12 |
12 |
$859.82 |
| 84479 |
|
245 |
234 |
$827.41 |
| 87088 |
|
534 |
491 |
$801.50 |
| 73590 |
|
63 |
60 |
$735.35 |
| 74021 |
|
25 |
25 |
$729.14 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
140 |
127 |
$698.65 |
| 87077 |
|
183 |
162 |
$655.43 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
817 |
707 |
$628.00 |
| 15853 |
|
12 |
12 |
$523.32 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
150 |
132 |
$473.08 |
| 87807 |
|
199 |
192 |
$454.71 |
| 76770 |
|
12 |
12 |
$433.46 |
| 74018 |
|
41 |
38 |
$415.07 |
| OP637 |
|
803 |
485 |
$401.55 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
424 |
364 |
$387.65 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
251 |
237 |
$375.05 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
382 |
295 |
$370.39 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$366.30 |
| 97535 |
Self-care/home management training, each 15 minutes |
16 |
15 |
$342.08 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
369 |
338 |
$313.93 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17 |
15 |
$293.73 |
| 87081 |
|
105 |
100 |
$277.22 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
475 |
347 |
$277.02 |
| 87205 |
|
135 |
120 |
$260.44 |
| 94664 |
|
14 |
14 |
$243.39 |
| 97803 |
|
12 |
12 |
$242.40 |
| 87147 |
|
39 |
27 |
$196.88 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
506 |
440 |
$178.37 |
| 80320 |
|
114 |
100 |
$172.85 |
| 82728 |
|
14 |
14 |
$168.06 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
126 |
98 |
$156.45 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28 |
13 |
$145.48 |
| 76857 |
|
12 |
12 |
$141.02 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$132.57 |
| 82746 |
|
13 |
13 |
$113.81 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
288 |
258 |
$108.81 |
| 86140 |
|
42 |
39 |
$95.71 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
84 |
66 |
$94.44 |
| 83550 |
|
14 |
14 |
$79.47 |
| 81002 |
|
262 |
253 |
$79.27 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
108 |
68 |
$66.50 |
| 82553 |
|
14 |
14 |
$61.49 |
| 83540 |
|
14 |
14 |
$52.53 |
| 85651 |
|
38 |
37 |
$48.70 |
| 82248 |
|
14 |
14 |
$43.50 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
32 |
30 |
$43.12 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
16 |
16 |
$34.20 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
20 |
20 |
$32.06 |
| J2060 |
Injection, lorazepam, 2 mg |
97 |
76 |
$27.40 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
48 |
42 |
$26.31 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
59 |
54 |
$25.84 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
15 |
15 |
$19.90 |
| 85652 |
|
15 |
12 |
$15.35 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
18 |
15 |
$13.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
32 |
25 |
$9.85 |
| 81015 |
|
33 |
31 |
$7.17 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
84 |
66 |
$1.00 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
15 |
15 |
$0.00 |